Jeppesen et al. 2016
Back to overview
Jeppesen SM, Yderstraede KB, Rasmussen BS, Hanna M, Lund L. Extracorporeal shockwave therapy in the treatment of chronic diabetic foot ulcers: a prospective randomised trial. J Wound Care. 2016 Nov 2;25(11):641-649.
Design: Prospective Randomised Trial Subjects: 23 patients with chronic diabetic foot ulcers (DFUs) classified as Wagner ulcer groups 1 and 2. Methods: Patients with chronic DFUs were randomised (1:1) to receive either: 1.A series of six focused ESWT treatments over 3 weeks in combination with standard care (n=11) 2.Standard care alone (n=12) Outcomes included: : Ulcer size, transcutaneous oxygen tension (TcPO2) and pain score at baseline, 3 weeks, 5 weeks and 7 weeks. Results: • Transcutaneous oxygen tension was significantly increased in the ESWT group compared with those receiving standard care alone at 3 weeks (p=0.044). • Ulcer area reduction was 34.5% in the intervention group versus 5.6% in the control group at 7 weeks (p=0.387). • Within-group analysis revealed a significant reduction of ulcer area in the intervention group (p<0.01), while healing was not demonstrated in the control group (p>0.05). • No significant decrease in pain scores comparing the intervention and control group was detected at weeks 3, 5 and 7.
Key message: Extracorporeal shockwave therapy resulted in significantly increased tissue oxygenation at 3 weeks and significantly reduced ulcer area across 7 weeks compared to standard care alone.
iEnovis
Pubmed
20
© 2022 Enovis Corporation
CONFIDENTIAL
Made with FlippingBook - PDF hosting